NCT02793960View on ClinicalTrials.gov

Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 10, 2016

Primary Completion Date

August 26, 2019

Study Completion Date

August 26, 2019

Conditions
Epidermolysis Bullosa
Interventions
DRUG

topical BPM31510 3.0% Cream

Application of drug to lesions of epidermolysis bullosa

Trial Locations (1)

33136

University of Miami Department of Dermatology, Miami

All Listed Sponsors
collaborator

BPGbio

INDUSTRY

lead

Shasa Hu

OTHER

NCT02793960 - Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa | Biotech Hunter | Biotech Hunter